Journal profile · Medicine-Pharmacology (medical)
Research Results in Pharmacology
ISSN 2658-381X · Belgorod State National Research University · Bulgaria
Research Results in Pharmacology: diamond open access (no APC); no APC; review about 12 weeks (community reports); 58 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Research Results in Pharmacology is published by Belgorod State National Research University. By OpenAlex counts of its recent articles, its largest topics are Neurological Disorders and Treatments, Nitric Oxide and Endothelin Effects and Synthesis and biological activity, together about 23% of its articles. Its main subfields are Cellular and Molecular Neuroscience. (generated from OpenAlex topic counts and CAS ranking data)
Research Results in Pharmacology is a peer-reviewed, open access, online journal covering various aspects of pharmacology. The Journal publishes articles in the field of pharmacotherapy, pharmacokinetics, pharmacoepidemiology, personalized therapy, multicenter studies, molecular screening, evidence-based medicine, proteomics, cellular technologies, results of experimental studies in modeling abnormalities in laboratory animals and clinical studies. Research Results in Pharmacology is established to facilitate the international cooperation in pharmacological research through: (1) English-language publication of high-quality work performed in Russia and other neighboring countries, following the highest possible publishing standards, and (2) involvement of foreign researchers in joint scientific and publication projects. Research Results in Pharmacology is a diamond open access journal, which means it is free to publish, read, distribute and re-use, thanks to the financial support of the Belgorod National Research University (BelSU). The articles are published online when ready in four issues a year. Research Results in Pharmacology will consider for publication articles on: promising pharmacological targets, highly efficient molecular screening with the use of modern methods of proteomics, cellular technologies, experimental studies in modeling abnormalities in laboratory animals, new experimental models on transgenic animals and their use in experimental pharmacology, historical issues of experimental and clinical pharmacology, structure-action analysis of innovative molecules and forecasting pharmacological activity, issues of metabolomics, clinical studies in the field of pharmacotherapy, pharmacokinetics, pharmacoepidemiology, personalized therapy, multicenter studies and evidence-based medicine. The following categories of articles will be considered: original research articles, reviews - longer articles, offering a comprehensive overview, historical analysis or/and future perspectives of a topic, short communications, discussion papers, methods, data papers, book reviews, monographs and collections of papers with no limit in size, published as 'special issues’. The Journal publishes electronic versions of the articles when these are ready to publish, without delays that might be caused by the completion of an issue. These electronic versions are not "pre-prints" but final and immutable versions of record. The date indicated on the electronic version i
From the journal's Aims & Scope
Research area (LetPub): Medicine-Pharmacology (medical)
Editor-in-chief Pokrovskii M.V.Publisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Neurological Disorders and TreatmentsNeuroscience8.6%
- Nitric Oxide and Endothelin EffectsMedicine8.1%
- Synthesis and biological activityChemistry6.2%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience5.7%
- Cardiac Ischemia and ReperfusionMedicine4.8%
- Neuropeptides and Animal PhysiologyNeuroscience4.6%
- Pain Mechanisms and TreatmentsMedicine4.3%
- Wound Healing and TreatmentsMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Pharmaceutical Science | Q3 | 131/191 | 31st |
| Pharmacology (medical) | Q4 | 213/278 | 23rd |
| Pharmacology | Q4 | 263/328 | 19th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceCASPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Scilit, Naver, Crossref, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.2LetPub ·
- SJR 2026-06
- 0.2LetPub ·
- SNIP 2026-06
- 0.42LetPub ·
- h-index
- 13OpenAlex ·
- i10-index
- 23OpenAlex ·
- 2-year mean citedness
- 0.58OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 450 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 42 | 42 | 132 |
| 2025 | 58 | 58 | 174 |
| 2024 | 43 | 43 | 137 |
| 2023 | 43 | 43 | 165 |
| 2022 | 47 | 47 | 171 |
| 2021 | 38 | 38 | 95 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Keywords
- ≤ 8
- Reference style
- APA
Policy excerpts from the journal's websiteAuthorship, Peer review
- Authorship
Manuscripts must be in grammatically correct English, certified as fluent or professionally edited. Model summary
All papers should be in grammatically correct English. Authors are asked to certify that their manuscripts are written in fluent English or edited by a professional English language editor prior to submission.
Source ↗Publisher website ·- Peer review
Double-blind peer review; manuscripts submitted as two separate files (cover part with personal information, anonymised main part). Model summary
Due to the double-blind peer review system, you have to submit your manuscript (apart from the letter to the editor and supplementary material) as two separate files
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Belgorod State National Research University
- Country or region
- Bulgaria
- Language
- English
- ISSN
- 2658-381X
- Print ISSN
- 2500-235X
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Research Results in Pharmacology
How long does peer review take at Research Results in Pharmacology?
Authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Research Results in Pharmacology?
According to the journal's author guidelines: Keywords: ≤ 8; Reference style: APA. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Research Results in Pharmacology?
According to LetPub and DOAJ records, Research Results in Pharmacology is indexed in Scopus and DOAJ. The journal's website also lists Web of Science and CAS; that list has not been checked against each database.
Is Research Results in Pharmacology open access, and what is the APC?
Research Results in Pharmacology is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .